TABLE 1

Study settings and treatment protocols of the in vivo experiments

StudyBleomycin-Induced Lung FibrosisSilica-Induced Lung Fibrosis
PreventiveTherapeuticPreventiveTherapeutic
Dose (mg/kg)30, 6030, 6030, 10030, 100
Study duration (day)14213030
Compound administration (day)0–147–210–3010–30
20–30
  • Posology, once daily, oral.